Medtronic plc (MDT)

Market Cap	110.21B
Revenue (ttm)	33.54B
Net Income (ttm)	4.66B
Shares Out	1.28B
EPS (ttm)	3.61
PE Ratio	23.83
Forward PE	15.50
Dividend	$2.84 (3.30%)
Ex-Dividend Date	Jun 27, 2025

Volume	9,222,393
Open	85.50
Previous Close	85.47
Day's Range	85.22 - 86.52
52-Week Range	75.96 - 96.25
Beta	0.81
Analysts	Buy
Price Target	98.00 (+13.93%)
Earnings Date	Aug 19, 2025

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: NYSE
• Ticker Symbol: MDT
• Website: https://www.medtronic.com

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Analyst Forecast

According to 15 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is $98.0, which is an increase of 13.93% from the latest price.

Price Target

$98.0

(13.93% upside)

Analyst Consensus: Buy